Seminars in Hematology
Volume 43 , Pages S1-S2 , October 2006

Role of Intravenous Iron Therapy in Anemia Management: State of the Art

  • Photis Beris, MD (Guest Editor)

      Affiliations

    • Professor of Clinical Hematology, Geneva University Hospital, Geneva, Switzerland
    • ,
  • Alice Maniatis, MD (Guest Editor)

      Affiliations

    • NATA Chair, Professor Emeritus, University of Patras, Director, Hematology Division, Henry Dunant Hospital, Athens, Greece

References 

  1. Ganz T, Nemeth E. Iron imports (IV. Hepcidin and regulation of body iron metabolism). Am J Physiol Gastrointest Liver Physiol. 2006;290:G199–G203
  2. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–1023
  3. Beris P. The use of iron to increase red cell mass. Can J Anaesth. 2003;50(suppl):S3–S9
  4. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood. 2000;96:823–833
  5. National Kidney Foundation Kidney Disease Outcomes Quality Initiative. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47(suppl 3):S1–S145
  6. Locatelli F, Aljama P, Barany P, Canaud B, Carrera F, Eckardt KU, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(suppl 2):ii1–ii47
  7. Macdougall IC, Roche A. Administration of intravenous iron sucrose as a 2-minute push to CKD patients: A prospective evaluation of 2,297 injections. Am J Kidney Dis. 2005;46:283–289
  8. Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, Bahrain H, et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol. 2004;22:1301–1307
  9. Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease—A randomized, controlled, open-label, multicenter study. Am J Gastroenterol. 2005;100:2503–2509
  10. Piagnerelli M, Vincent JL. Role of iron in anaemic critically ill patients: It’s time to investigate!. Crit Care. 2004;8:306–307
  11. Breymann C, Richter C, Huttner C, Huch R, Huch A. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. Eur J Clin Invest. 2000;30:154–161
  12. Breymann C, Visca E, Huch R, Huch A. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. Am J Obstet Gynecol. 2001;184:662–667
  13. Cuenca J, Garcia-Erce JA, Martinez AA, Solano VM, Molina J, Munoz M. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: Preliminary data. Arch Orthop Trauma Surg. 2005;125:342–347
  14. Garcia-Erce JA, Cuenca J, Munoz M, Izuel M, Martinez AA, Herrera A, et al. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture (A prospective observational study). Vox Sang. 2005;88:235–243

PII: S0037-1963(06)00156-9

doi: 10.1053/j.seminhematol.2006.08.001

Seminars in Hematology
Volume 43 , Pages S1-S2 , October 2006

Article Tools